Cargando…

Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response

OBJECTIVES: This study aimed to determine if changes in myeloperoxidase (MPO) levels correlate with response to cardiac resynchronization therapy (CRT) and the potential role of MPO as a predictor of response to CRT. BACKGROUND: CRT is a well-established treatment option in chronic heart failure (CH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sultan, A., Wörmann, J., Lüker, J., v. d. Bruck, J. -H., Plenge, T., Rudolph, V., Klinke, A., Heijman, J., Mollenhauer, M., Ravekes, T., Baldus, S., Steven, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318955/ https://www.ncbi.nlm.nih.gov/pubmed/32564144 http://dx.doi.org/10.1007/s00392-020-01690-1

Ejemplares similares

ICD therapy in the elderly: a retrospective single-center analysis of mortality
por: Scheurlen, Cornelia, et al.
Publicado: (2021)

Impact of ventricular arrhythmia management on suboptimal biventricular pacing in cardiac resynchronization therapy
por: van den Bruck, Jan-Hendrik, et al.
Publicado: (2022)

Myeloperoxidase deficiency preserves vasomotor function in humans
por: Rudolph, Tanja K., et al.
Publicado: (2012)

Lung Neutrophilia in Myeloperoxidase Deficient Mice during the Course of Acute Pulmonary Inflammation
por: Kremserova, Silvie, et al.
Publicado: (2016)

Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins
por: Friedrichs, Kai, et al.
Publicado: (2014)

Procedural and outcome impact of obesity in cryoballoon versus radiofrequency pulmonary vein isolation in atrial fibrillation patients
por: Scheurlen, Cornelia, et al.
Publicado: (2022)

Protective Effects of Therapeutic Neutrophil Depletion and Myeloperoxidase Inhibition on Left Ventricular Function and Remodeling in Myocardial Infarction
por: Guthoff, Henning, et al.
Publicado: (2022)

A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients
por: Khalilova, Irada S., et al.
Publicado: (2018)

Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease
por: MAYYAS, FADIA A., et al.
Publicado: (2014)

Pulmonary vein isolation in a patient with congenital pulmonary atresia: a case report
por: Plenge, Tobias, et al.
Publicado: (2019)

Myeloperoxidase Deficiency Alters the Process of the Regulated Cell Death of Polymorphonuclear Neutrophils
por: Kremserová, Silvie, et al.
Publicado: (2022)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

Decreased Plasma Myeloperoxidase Associated with Probiotic Therapy in Autistic Children
por: Russo, Anthony J.
Publicado: (2015)

The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
por: Kargapolova, Yulia, et al.
Publicado: (2021)

A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma
por: Goiffon, Reece J., et al.
Publicado: (2015)

Pulmonary vein isolation for atrial fibrillation using true high-power short-duration vs. cryoballoon ablation
por: Wörmann, Jonas, et al.
Publicado: (2023)

Predictors of positive response to cardiac resynchronization therapy
por: Rinkuniene, Diana, et al.
Publicado: (2014)

Myeloperoxidase is not a good biomarker for preeclampsia prediction
por: Rocha-Penha, L., et al.
Publicado: (2017)

Implementation and first outcomes of a novel standard operating procedure for preprocedural transoesophageal echocardiography screening in course of atrial arrhythmia ablation
por: Dittrich, Sebastian, et al.
Publicado: (2023)

A transgenic zebrafish line for in vivo visualisation of neutrophil myeloperoxidase
por: Buchan, Kyle D., et al.
Publicado: (2019)

Tricuspid regurgitation after cardiac resynchronization therapy: evolution and prognostic significance( )
por: Stassen, Jan, et al.
Publicado: (2022)

Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach
por: Lobbes, M. B. I., et al.
Publicado: (2010)

Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response
por: Yang, Shengwen, et al.
Publicado: (2020)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
por: Olson, S. W., et al.
Publicado: (2017)

Effects of methylprednisolone on exercise-induced increases of plasma levels of polymorphonuclear elastase and myeloperoxidase in man. Preliminary results
por: Camus, G., et al.
Publicado: (1993)

Electrocardiographic Parameters as Predictors of Response to Cardiac Resynchronization Therapy
por: Poposka, Lidija, et al.
Publicado: (2018)

Incidence and predictors of super-response to cardiac resynchronization therapy
por: Rohit, Manoj Kumar, et al.
Publicado: (2019)

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias
por: Hozumi, Hironao, et al.
Publicado: (2018)

Septal rebound stretch as predictor of echocardiographic response to cardiac resynchronization therapy
por: Ghani, Abdul, et al.
Publicado: (2015)

Myeloperoxidase-derived damage to human plasma fibronectin: Modulation by protein binding and thiocyanate ions (SCN(−))
por: Vanichkitrungruang, Siriluck, et al.
Publicado: (2020)

Early real-world experience using temperature-guided diamond tip facilitated high-power ablation for catheter ablation of atrial fibrillation
por: Dittrich, Sebastian, et al.
Publicado: (2023)

Myeloperoxidase in Health and Disease
por: Ortiz-Cerda, Tamara, et al.
Publicado: (2023)

Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy
por: Rocha, Eduardo Arrais, et al.
Publicado: (2015)

Genetic variation in the myeloperoxidase gene and cognitive impairment in Multiple Sclerosis
por: Manna, I, et al.
Publicado: (2006)

Inactivation of human myeloperoxidase by hydrogen peroxide()
por: Paumann-Page, Martina, et al.
Publicado: (2013)

Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry
por: Sultan, A., et al.
Publicado: (2017)

Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflammed liver
por: Amanzada, Ahmad, et al.
Publicado: (2011)

Measuring Myeloperoxidase Activity in Biological Samples
por: Pulli, Benjamin, et al.
Publicado: (2013)

Full blood count as potential predictor of outcomes in patients undergoing cardiac resynchronization therapy
por: Papageorgiou, Nikolaos, et al.
Publicado: (2019)

Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO
por: Friedrichs, Kai, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qb3v5acaj0br6qmugaql0jsu9r